Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion type Assertion NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_head.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_provenance.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion evidence source_evidence_literature NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_provenance.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion SIO_000772 12738753 NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_provenance.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion wasDerivedFrom befree-20140225 NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_provenance.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion wasGeneratedBy ECO_0000203 NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_provenance.